Discontinuation report TEVA-LISINOPRIL/HCTZ (TYPE P)

Last updated on 2019-04-11 History
Report ID 81368
Drug Identification Number 02302152
Brand name TEVA-LISINOPRIL/HCTZ (TYPE P)
Common or Proper name LISINOPRIL/HCTZ (TYPE P)
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LISINOPRIL
Strength(s) 25MG 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-01-09
Remaining supply date 2019-03-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-04-11 French Compare
v1 2019-04-11 English Compare

Showing 1 to 2 of 2